Cargando…

CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis

Detalles Bibliográficos
Autores principales: Cross, A.H., Girard, T.J., Giacoletto, K.S., Evans, R.J., Karr, R.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119817/
http://dx.doi.org/10.1016/0165-5728(94)90286-0
_version_ 1783514840455708672
author Cross, A.H.
Girard, T.J.
Giacoletto, K.S.
Evans, R.J.
Karr, R.W.
author_facet Cross, A.H.
Girard, T.J.
Giacoletto, K.S.
Evans, R.J.
Karr, R.W.
author_sort Cross, A.H.
collection PubMed
description
format Online
Article
Text
id pubmed-7119817
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71198172020-04-08 CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis Cross, A.H. Girard, T.J. Giacoletto, K.S. Evans, R.J. Karr, R.W. J Neuroimmunol Article Published by Elsevier B.V. 1994-10 2002-12-10 /pmc/articles/PMC7119817/ http://dx.doi.org/10.1016/0165-5728(94)90286-0 Text en Copyright © 1994 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Cross, A.H.
Girard, T.J.
Giacoletto, K.S.
Evans, R.J.
Karr, R.W.
CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title_full CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title_fullStr CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title_full_unstemmed CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title_short CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
title_sort ctla4-ig treatment prevents murine experimental autoimmune encephalomyelitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119817/
http://dx.doi.org/10.1016/0165-5728(94)90286-0
work_keys_str_mv AT crossah ctla4igtreatmentpreventsmurineexperimentalautoimmuneencephalomyelitis
AT girardtj ctla4igtreatmentpreventsmurineexperimentalautoimmuneencephalomyelitis
AT giacolettoks ctla4igtreatmentpreventsmurineexperimentalautoimmuneencephalomyelitis
AT evansrj ctla4igtreatmentpreventsmurineexperimentalautoimmuneencephalomyelitis
AT karrrw ctla4igtreatmentpreventsmurineexperimentalautoimmuneencephalomyelitis